Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Dow Inc. (NYSE: DOW) securities between January 30, 2025 and July 23, 2025, all dates inclusive (the “Class Period”), have until this upcoming Tuesday, October 28, 2025 to seek appointment as lead plaintiff of the Dow class action lawsuit. Captioned Sarti v. Dow […]

NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zynex, Inc. ("Zynex" or "the Company") (NASDAQ:ZYXI). Investors who purchased Zynex securities prior to March 13, 2023, and continue to hold to the present, are encouraged to

NEW YORK, NY, NY / ACCESS Newswire / October 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of F5, Inc. ("F5" or "the Company") (NASDAQ:FFIV). Investors who purchased F5 securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/FFIV. Investigation

NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Neogen Corporation ("Neogen" or "the Company") (NASDAQ:NEOG). Investors who purchased Neogen securities prior to January 5, 2025, and continue to hold to the present, are encouraged to obtain additional

NEW YORK, NY, NY / ACCESS Newswire / October 26, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ:LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Stitch Fix, Inc. ("Stitch Fix" or "the Company") (NASDAQ:SFIX). Investors who purchased Stitch Fix securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s

NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate ("Cytokinetics" or the "Company") (NASDAQ:CYTK).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK, NY, NY / ACCESS Newswire / October 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fortrea Holdings, Inc. ("Fortrea" or "the Company") (NASDAQ:FTRE). Investors who purchased Fortrea securities prior to July 3, 2023, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MGP Ingredients, Inc. ("MGP Ingredients" or "the Company") (NASDAQ:MGPI). Investors who purchased MGP Ingredients securities prior to May 4, 2023, and continue to hold to the present,

NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rocket Pharmaceuticals, Inc. ("Rocket" or "the Company") (NASDAQ:RCKT). Investors who purchased Rocket securities prior to September 17, 2024, and continue to hold to the present, are encouraged to obtain